Monopar Therapeutics Inc (MNPR)
ETFs that hold Monopar Therapeutics Inc (MNPR)
Monopar Therapeutics Inc is held by 3 ETFs tracked in our database. The largest position is held by XBI (0.10%), a sector fund. The remaining funds hold it at 0.01% or less. The largest holders are all small-cap and sector funds.
ETFs holding Monopar Therapeutics Inc (MNPR) in our database, ranked by portfolio weight.
Symbol | Name | Weight |
|---|---|---|
| XBI | SPDR S&P Biotech ETF | 0.10% |
| IWM | iShares Russell 2000 ETF | 0.01% |
| IWO | iShares Russell 2000 Growth ETF | 0.01% |
Which ETFs hold Monopar Therapeutics Inc (MNPR)?
The ETFs with the largest positions in Monopar Therapeutics Inc (MNPR) are: SPDR S&P Biotech ETF (XBI, 0.10%); iShares Russell 2000 ETF (IWM, 0.01%); iShares Russell 2000 Growth ETF (IWO, 0.01%). The full list, ranked by weight, is in the table.
How many ETFs hold Monopar Therapeutics Inc (MNPR)?
Monopar Therapeutics Inc (MNPR) is held by 3 ETFs tracked in our database. The largest position is in XBI, where it makes up 0.10% of the fund's assets.
What does the ETF weight mean?
The weight is the share of a fund's assets invested in the stock. It shows how much passive index-fund ownership the stock has and where it carries the most influence. XBI holds Monopar Therapeutics Inc (MNPR) at 0.10%, and the simple average weight across the 3 funds is 0.04%.